Erector Spinae Plane Block for Postoperative Pain After Kidney Stone Surgery
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are using opioids regularly, you may not be eligible to participate.
What data supports the effectiveness of the treatment Erector Spinae Plane Block for Postoperative Pain After Kidney Stone Surgery?
Is the Erector Spinae Plane Block generally safe for humans?
The Erector Spinae Plane Block is generally considered safe, but there have been rare cases of unwanted spread of the anesthetic to areas near the spine, which can cause complications. In a study, patients receiving this block for kidney stone surgery showed effective pain relief without significant safety concerns.12467
How does the erector spinae plane block treatment differ from other treatments for postoperative pain after kidney stone surgery?
The erector spinae plane block (ESP block) is unique because it is a simple and safe method that involves injecting a local anesthetic near the spine to block pain signals, providing effective pain relief after kidney stone surgery. Unlike traditional intravenous pain medications, the ESP block targets specific nerves, potentially reducing the need for systemic painkillers and their side effects.13458
What is the purpose of this trial?
This is a randomized, triple-masked, placebo-controlled parallel-arm human subjects clinical trial investigating the addition of a continuous erector spinae plane nerve block to a single-injection erector spinae plane block to provide postoperative analgesia following percutaneous nephrolithotomy. Participants will all receive a single-injection nerve block and perineural catheter insertion. Following surgery, participants will be randomly allocated to receive either perineural local anesthetic or normal saline until the second day following surgery.
Research Team
Brian Ilfeld, MD
Principal Investigator
University of California, San Diego
Eligibility Criteria
This trial is for adults over 18 who are having a kidney stone removal surgery called unilateral percutaneous nephrolithotomy and will receive an erector spinae plane block for pain. It's not for pregnant individuals, those with allergies to the drugs used, kidney problems, chronic opioid use or abuse, severe health issues limiting function, extreme obesity, or if they can't communicate with staff.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Procedures
Baseline anthropometric information is recorded, and a peripheral IV catheter is inserted. Participants receive midazolam and fentanyl for comfort.
Treatment
Participants undergo percutaneous nephrolithotomy and receive a single-injection nerve block and perineural catheter insertion. Randomized to receive either bupivacaine or saline.
Postoperative Monitoring
Participants are monitored for pain management and catheter function. Perineural catheters are removed upon study infusate reservoir exhaustion.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including pain and opioid consumption assessments.
Treatment Details
Interventions
- Bupivacaine 0.25%
- Continuous Erector Spinae Plane Blocks
- Normal Saline
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor